Lung Surfactant for Pulmonary Barrier Restoration in Patients With COVID-19 Pneumonia

Lung Surfactant for Pulmonary Barrier Restoration in Patients With COVID-19 Pneumonia

Bibliographic Details
Main Authors:	Ursula Mirastschijski, Rolf Dembinski, Kathrin Maedler
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-05-01
Series:	Frontiers in Medicine
Subjects:	COVID-19 SARS-CoV-2 pneumonia lung surfactant ARDS inflammation
Online Access:	https://www.frontiersin.org/article/10.3389/fmed.2020.00254/full

Similar Items

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
by: Shengguang Wang, et al.
Published: (2021-06-01)

Surfactant alteration and replacement in acute respiratory distress syndrome
by: Walmrath Dieter, et al.
Published: (2001-10-01)

Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits
by: J. Zebialowicz Ahlström, et al.
Published: (2019-11-01)

Assessment of pulmonary surfactant in COVID-19 patients
by: Peter Schousboe, et al.
Published: (2020-09-01)

Human neutrophil elastase and lung surfactant in acute respiratory distress syndrome
by: Odalys Blanco, et al.

The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia Management
by: Marina Lugarà, et al.
Published: (2022-07-01)

Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients
by: Adrian Krygier, et al.
Published: (2022-12-01)

The Effect of Modified Porcine Surfactant Alone or in Combination with Polymyxin B on Lung Homeostasis in LPS-Challenged and Mechanically Ventilated Adult Rats
by: Maros Kolomaznik, et al.
Published: (2020-09-01)

Pneumonia a Varicella zoster Varicella zoster pneumonia
by: Carla Ferreira Santos, et al.
Published: (2010-06-01)

The hydrophilic proteins of lung surfactant as a prognostic marker in experimental pneumonia
by: Mohammad Reza Mokhber Dezfouli, et al.
Published: (2017-01-01)

Pulmonary Surfactant in Adult ARDS: Current Perspectives and Future Directions
by: Ahilanandan Dushianthan, et al.
Published: (2023-09-01)

Exogenous surfactant prevents hyperoxia-induced lung injury in adult mice
by: Frank Silva Bezerra, et al.
Published: (2019-03-01)

Lung Transplantation as a way to Escape Pneumonia in Patients with COVID-19: Lessons from ARDS and Influenza
by: Reyhaneh Shams Khozani, et al.
Published: (2021-07-01)

Linking Ventilator Injury-Induced Leak across the Blood-Gas Barrier to Derangements in Murine Lung Function
by: Bradford J. Smith, et al.
Published: (2017-07-01)

The Role of Pulmonary Surfactant Phospholipids in Fibrotic Lung Diseases
by: Beatriz Tlatelpa-Romero, et al.
Published: (2022-12-01)

Pulmonary haptoglobin (pHp) is part of the surfactant system in the human lung
by: Abdullah Mahdi, et al.
Published: (2012-11-01)

Clinical case of nebulized surfactant therapy for severe COVID-19-associated pneumonia at the 2nd stage of rehabilitation treatment
by: I. Yu. Stulikova, et al.
Published: (2021-10-01)

Lung surfactant in subacute pulmonary disease
by: Spragg Roger G, et al.
Published: (2002-04-01)

Malondialdehyde Acetaldehyde-Adduction Changes Surfactant Protein D Structure and Function
by: Claire G. Nissen, et al.
Published: (2022-05-01)

Emergency Lung Transplantation after COVID-19: Immunopathological Insights on Two Affected Patients
by: Giorgio A. Croci, et al.
Published: (2021-03-01)

Association of SP-A and SP-D Surfactant Proteins with the Severity of CommunityAcquired Pneumonia
by: O. S. Kharlamova, et al.
Published: (2020-10-01)

Acute Respiratory Distress Syndrome and Time to Weaning Off the Invasive Mechanical Ventilator among Patients with COVID-19 Pneumonia
by: Jose Bordon, et al.
Published: (2021-06-01)

The Experience of Surfactant Therapy in Severe COVID-19 Pneumonia: A Case Report
by: Igor N. Banin, et al.
Published: (2021-06-01)

Surfactant proteins A and D: role in the pathogenesis of community-acquired pneumonia and possible predictive perspectives
by: O. S. Kharlamovа, et al.
Published: (2020-03-01)

Insights Gained Into the Treatment of COVID19 by Pulmonary Surfactant and Its Components
by: Dan Li, et al.
Published: (2022-05-01)

Co-aerosolized Pulmonary Surfactant and Ambroxol for COVID-19 ARDS Intervention: What Are We Waiting for?
by: Pradeep Kumar
Published: (2020-09-01)

Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
by: Ulf Andersson, et al.
Published: (2020-05-01)

Neonatal varicella pneumonia, surfactant replacement therapy
by: Mousa Ahmadpour-kacho, et al.
Published: (2015-12-01)

Surfactant protein D: a useful marker for differentiation of drug-induced pneumonia and bacterial pneumonia
by: Yuko Waseda, et al.
Published: (2021-06-01)

Circulating Surfactant Protein D: A Biomarker for Acute Lung Injury?
by: Alyssa Elmore, et al.
Published: (2023-09-01)

Alveolar Tissue Fiber and Surfactant Effects on Lung Mechanics—Model Development and Validation on ARDS and IPF Patients
by: Jiayao Yuan, et al.
Published: (2021-01-01)

Molecular Impact of Conventional and Electronic Cigarettes on Pulmonary Surfactant
by: Maria Lisa Garavaglia, et al.
Published: (2023-07-01)

Activity and biophysical inhibition resistance of a novel synthetic lung surfactant containing Super-Mini-B DATK peptide
by: Robert H. Notter, et al.
Published: (2016-01-01)

Endotracheal Surfactant Combined With Budesonide for Neonatal ARDS
by: Burak Deliloglu, et al.
Published: (2020-05-01)

Benefits of Steroid Therapy in COVID-19 Patients with Different PaO<sub>2</sub>/FiO<sub>2</sub> Ratio at Admission
by: Serena Vita, et al.
Published: (2021-07-01)

Acute Respiratory Distress Syndrome (ARDS) pada Pneumonia COVID-19
by: Arie Zainul Fatoni, et al.
Published: (2021-01-01)

Morphological changes in the membranogenic pulmonary edema after replacement surfactant therapy administration
by: Novikov N.Yu.
Published: (2012-01-01)

Too much tolerance for hyperoxemia in mechanically ventilated patients with SARS-CoV-2 pneumonia? Report from an Italian intensive care unit
by: Elisa Damiani, et al.
Published: (2022-07-01)

A recipe for a good clinical pulmonary surfactant
by: Jesús Pérez-Gil
Published: (2022-08-01)

Aerosol delivery of synthetic lung surfactant
by: Frans J. Walther, et al.
Published: (2014-05-01)